Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 445,763 | 466,789 | 425,720 | 434,055 | 354,868 |
| Cost of Goods | 274,411 | 289,615 | 269,450 | 264,308 | 214,100 |
| Gross Profit | 171,352 | 177,174 | 156,270 | 169,747 | 140,768 |
| Operating Expenses | 102,057 | 108,565 | 97,925 | 111,994 | 89,396 |
| Operating Income | 69,706 | 69,224 | 58,795 | 58,061 | 51,472 |
| Interest Expense | 6,983 | 7,510 | 7,079 | 8,909 | 4,211 |
| Other Income | 15,324 | 2,011 | 1,540 | 5,238 | 4,289 |
| Pre-tax Income | 78,047 | 63,725 | 53,256 | 54,390 | 51,550 |
| Income Tax | 31,084 | 18,450 | 15,565 | 18,845 | 13,975 |
| Net Income Continuous | 46,963 | 45,275 | 37,691 | 35,545 | 37,575 |
| Net Income Discontinuous | -4 | -48 | 342 | 12 | -26 |
| Minority Interests | 181 | 547 | 298 | 350 | 406 |
| Net Income | $46,778 | $44,680 | $37,735 | $35,207 | $37,143 |
| EPS Basic Total Ops | 0.98 | 0.94 | 0.80 | 0.75 | 0.80 |
| EPS Basic Continuous Ops | 0.98 | 0.94 | 0.79 | 0.75 | 0.80 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.97 | 0.93 | 0.79 | 0.73 | 0.78 |
| EPS Diluted Continuous Ops | 0.97 | 0.93 | 0.78 | 0.73 | 0.78 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $102,117 | $104,766 | $92,903 | $90,414 | $76,127 |